Alkem Laboratories’ consolidated net profit soared 91% to Rs 550 crore for Q1 FY24-25, compared to Rs 288 crore last year. Total income rose to Rs 3,152 crore from Rs 3,033 crore. The company attributes the profit boost to strong sales and improved margins. Alkem’s stock gained 1.86% to Rs 5,793.15 on BSE. Strong profit growth indicates robust operational performance, positively influencing investor sentiment and stock value.
